| # | Drug | Count |
|---|---|---|
| 0 | DABRAFENIB | 29 |
| 1 | TRAMETINIB | 28 |
| 2 | CARBOPLATIN | 10 |
| 3 | PEMETREXED DISODIUM | 9 |
| 4 | PEMETREXED | 8 |
| 5 | OXALIPLATIN | 5 |
| 6 | PANITUMUMAB | 5 |
| 7 | BEVACIZUMAB | 4 |
| 8 | ENCORAFENIB | 4 |
| 9 | FLUOROURACIL | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DABRAFENIB | 29 | 0.0014 |
| 1 | TRAMETINIB | 28 | 0.0012 |
| 2 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 3 | AMINOPHYLLINE | 1 | 0.0005 |
| 4 | GEFITINIB | 4 | 0.0004 |
| 5 | ENCORAFENIB | 4 | 0.0004 |
| 6 | VEMURAFENIB | 4 | 0.0003 |
| 7 | PANITUMUMAB | 5 | 0.0003 |
| 8 | FRUQUINTINIB | 1 | 0.0003 |
| 9 | BINIMETINIB | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 | 0.0001 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 10 | 0.0001 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 16 | 0.0001 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 6 | Kinase Inhibitor [EPC] | 23 | 0.0000 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Alkaloid [EPC] | 1 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 5 | 0.0000 |